Connor, Clark & Lunn Investment Management »

Endo Pharmaceuticals shares owned by Connor, Clark & Lunn Investment Management

Quarter-by-quarter ownership of Endo Pharmaceuticals shares owned by Connor, Clark & Lunn Investment Management from 13F filings

Historical chart of Connor, Clark & Lunn Investment Management investment in Endo Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Endo Pharmaceuticals held by Connor, Clark & Lunn Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Endo Pharmaceuticals by Connor, Clark & Lunn Investment Management

Quarter filed Position value Share count Share price at filing
2013-12-31 $6.1M 85k 71.67
2013-09-30 $4.6M 98k 46.70
2013-06-30 $3.8M 97k 38.82